Literature DB >> 12235145

The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis.

Jing Wang1, Celeste E Kirby, Ronald Herbst.   

Abstract

PRL-1 is one of three closely related protein-tyrosine phosphatases, which are characterized by C-terminal farnesylation. Recent reports suggest that they are involved in the regulation of cell proliferation and transformation. However, their biological function has not yet been determined. Here we show that PRL-1 mRNA is overexpressed in a number of human tumor cell lines, including HeLa cells. Using immunofluorescence we studied the subcellular localization of endogenous PRL-1, and our results demonstrate that PRL-1 exhibits cell cycle-dependent localization; in non-mitotic HeLa cells, PRL-1 is localized to the endoplasmic reticulum in a farnesylation-dependent manner. In mitotic cells PRL-1 relocalizes to the centrosomes and the spindle apparatus, proximal to the centrosomes, in a farnesylation-independent manner. Conditional expression of a catalytic domain mutant in HeLa cells results in a delay in the progression of cells through mitosis but has no effect on other phases of the cell cycle. Further, expression of a farnesylation site PRL-1 mutant results in mitotic defects, characterized by chromosomal bridges in anaphase and lagging chromosomes, without affecting spindle checkpoint function. Together, these results suggest that PRL-1 function is regulated in a cell cycle-dependent manner and implicate PRL-1 in regulating progression through mitosis, possibly by modulating spindle dynamics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235145     DOI: 10.1074/jbc.M206407200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Characterization of farnesylated protein tyrosine phosphatase TcPRL-1 from Trypanosoma cruzi.

Authors:  Ileana C Cuevas; Peter Rohloff; Daniel O Sánchez; Roberto Docampo
Journal:  Eukaryot Cell       Date:  2005-09

2.  PRL-1 protein promotes ERK1/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein.

Authors:  Yunpeng Bai; Yong Luo; Sijiu Liu; Lujuan Zhang; Kui Shen; Yuanshu Dong; Chad D Walls; Lawrence A Quilliam; Clark D Wells; Youjia Cao; Zhong-Yin Zhang
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

3.  Oxidative stress-induced expression and modulation of Phosphatase of Regenerating Liver-1 (PRL-1) in mammalian retina.

Authors:  Ling Yu; Una Kelly; Jessica N Ebright; Goldis Malek; Peter Saloupis; Dennis W Rickman; Brian S McKay; Vadim Y Arshavsky; Catherine Bowes Rickman
Journal:  Biochim Biophys Acta       Date:  2007-06-26

4.  Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues.

Authors:  Carmen M Dumaual; George E Sandusky; Pamela L Crowell; Stephen K Randall
Journal:  J Histochem Cytochem       Date:  2006-09-06       Impact factor: 2.479

5.  PRL2/PTP4A2 phosphatase is important for hematopoietic stem cell self-renewal.

Authors:  Michihiro Kobayashi; Yunpeng Bai; Yuanshu Dong; Hao Yu; Sisi Chen; Rui Gao; Lujuan Zhang; Mervin C Yoder; Reuben Kapur; Zhong-Yin Zhang; Yan Liu
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

Review 6.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

Review 7.  Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.

Authors:  Michihiro Kobayashi; Sisi Chen; Rui Gao; Yunpeng Bai; Zhong-Yin Zhang; Yan Liu
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  The effect of pentamidine on melanoma ex vivo.

Authors:  Jason Smith; Benjamin J Stewart; Sharon Glaysher; Katharine Peregrin; Louise A Knight; David J Weber; Ian A Cree
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

Review 9.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

10.  Tipifarnib in the treatment of acute myeloid leukemia.

Authors:  Xavier Thomas; Mohamed Elhamri
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.